I have voted against any options or shares to Doug until we see the sales number for Febridx pick up. This is an excellent product and I dont think it should be very hard to sell something like Febridx. They need to come up with some out of the box ideas and work harder to improve the sales as I believe Viradx wouldnt be able to compete the chinese manufacturers and margins wouldnt be high.
Add to My Watchlist
What is My Watchlist?
